Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

The Insulin Confidence Code: Episode 3: Why the Right insulin matters - comparing basal options

Episode 4: Navigating Ongoing Insulin Titration Challenges

Episode on practical challenges in titrating basal insulin therapy over time.

Episode 5: Managing Hypoglycaemia Risk on Basal Insulin

Episode on recognising, preventing and managing hypoglycaemia risk during basal insulin therapy.

Episode 6: Supporting Long-Term Insulin Adherence in Clinical Practice

Final episode on sustaining treatment adherence in long-term basal insulin management.

The Insulin Confidence Code: Episode 7: Managing Diabetes in Special Populations

The Insulin Confidence Code: Episode 8: HIV & Diabetes and Patient Care Strategies

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin1.

Xem lại bản ghi hình Hội thảo khoa học trực tuyến "PHÒNG NGỪA BỆNH DO NÃO MÔ CẦU Ở TRẺ NHỎ - TỪ ĐỘT PHÁ CÔNG NGHỆ ĐẾN DỮ LIỆU LÂM SÀNG CỦA MenACYW-TT" diễn ra ngày 08/12/2025

Oppdaterte behandlingskriterier for Dupixent ved CRSwNP

Overlege Jörg Törpel gir en oppdatering av nye behandlingskriterier for behandling med Dupixent hos personer med alvorlig kronisk rhinosinusitt med nasal polypose (CRSwNP).

בייפורטוס

Rediffusion du DiabExpert Post-EASD 2025 - DT2 en mouvement : quoi de neuf?

La prise en charge du DT2 évolue avec les nouvelles données des congrès internationaux: synthèse des actualités récentes pour les professionnels de santé.

Rediffusion du DiabExpert Post-EASD 2025

La prise en charge du diabète intègre désormais risque cardiovasculaire, qualité de vie et accompagnement psychosocial, au-delà du seul contrôle glycémique.